Drug Type Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals |
Synonyms |
Target |
Mechanism PSMA modulators(Prostate-specific membrane antigen modulators), Ionising radiation emitters |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
PSMA-Positive Prostatic Cancer | IND Approval | CN | 30 Sep 2024 |